Autopsy report · NCT01621737

Antipsychotic Effects of Oxytocin

“Break in funding”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year after it had already started.
• Ran for about 7 years 6 months before it stopped.
• 42 participants enrolled.
• Results were posted on the registry 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

University of California, San Diego

Sponsor type

University, hospital or other

Conditions

Schizophrenia

Interventions

Oxytocin; Oxytocin; Placebo

Participants

42

Sites

2

Countries

United States

Trials that died the same way

• Evaluation of a Novel Microfluidic Device to Purify Metastatic Lung Cancer Patients CTC (Circulating Tumoral Cells)
  “funding ending” (76% match in meaning)
• Gas Supply, Demand and Middle Ear Gas Balance -- Diagnosis of Eustachian Tube Dysfunction
  “End of funding” (75% match in meaning)
• Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury
  “Funding Termination” (73% match in meaning)
• Efficacy of AposTherapy® in Knee OA
  “Halt in funding” (73% match in meaning)
• IRIS-BioFreedom Cohort in the IRIS-DES Registry
  “Funding issue” (72% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.